Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022 Read more
New data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration Read more
FDA grants priority review to Roche’s Lunsumio for Relapsed or Refractory Follicular Lymphoma Read more
